• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Wednesday, May 25, 2022
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home Business

Pfizer share price zooms over 19% to new 52-week high on COVID-19 vaccine news; rallies 63% since March

by The Outlooker Web Desk
November 15, 2020
in Business
0
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

Pfizer share price zoomed 19.5 per cent to scale to a fresh 52-week high of Rs 5,875 apiece in intraday on BSE, after the company along with German drugmaker BioNTech SE said that their vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19, based on initial data from a large study. The stock has rallied 63.73 per cent from its March low of Rs 3,588.15 apiece. The COVID-19 vaccine news fueled a rally across global stock markets. Pfizer also indicated that the company is on track later this month to file an emergency use application with US regulators. “Pfizer stock moved up due to positive commentary on Corona vaccine. Its future move depends on the success of this vaccine. Successful launch of such vaccine by any pharma would be a big game-changer for that company,” Mitul Shah, Head of Research at Reliance Securities, told The Outlooker Online.

Pfizer shares ended 2.66 per cent up at Rs 5,048.45 apiece on BSE, as compared to a 1.60 per cent rise in S&P BSE Sensex. The company in its press release said that along with the efficacy data generated from the clinical trial, Pfizer and BioNTech are working to prepare the necessary safety and manufacturing data to submit to the FDA to demonstrate the safety and quality of the vaccine product produced. “The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent COVID-19,” said Dr. Albert Bourla, Pfizer Chairman and CEO.

It may be noted that another US company, Moderna Inc, also has said it hopes to be able to file an application with the Food and Drug Administration later this month. The company in its statement said the Phase 3 clinical trial of BNT162b2 began on July 27 and has enrolled 43,538 participants to date, 38,955 of whom have received a second dose of the vaccine candidate as of November 8, 2020. “We are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis. We look forward to sharing additional efficacy and safety data generated from thousands of participants in the coming weeks,” Bourla said.

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
Deepawali 2020 Celebrations In Delhi Mumbai Amritsar Golden Temple Pics; Pollution In Delhi

Deepawali 2020 Celebrations In Delhi Mumbai Amritsar Golden Temple Pics; Pollution In Delhi

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Delhi Positivity Rate Falls To 13% From 16.3%, Cases Down 19% To 9,197
National

Coronavirus India LIVE Updates, Coronavirus Cases Today, COVID 19 Cases In India, Omicron Covid Cases, India Covid Cases May 25

May 25, 2022
Global Markets: Stocks slump on growth concerns, bond yields slip
Business

Global Markets: Stocks slump on growth concerns, bond yields slip

May 24, 2022
Tamil Nadu BJP Leader Balachandran Hacked To Death In Chennai: Police
National

Tamil Nadu BJP Leader Balachandran Hacked To Death In Chennai: Police

May 24, 2022
Coal India To Open Big, New Mine This Year To Fight Power Crisis
National

Coal India To Open Big, New Mine This Year To Fight Power Crisis

May 24, 2022

Connect with us

No Result
View All Result

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • Coronavirus India LIVE Updates, Coronavirus Cases Today, COVID 19 Cases In India, Omicron Covid Cases, India Covid Cases May 25
  • Global Markets: Stocks slump on growth concerns, bond yields slip
  • Tamil Nadu BJP Leader Balachandran Hacked To Death In Chennai: Police

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.